A detailed history of Titleist Asset Management, Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Titleist Asset Management, Ltd. holds 1,398 shares of AMGN stock, worth $436,805. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,398
Previous 1,581 11.57%
Holding current value
$436,805
Previous $356,000 3.09%
% of portfolio
0.09%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 12, 2023

SELL
$229.03 - $291.01 $41,912 - $53,254
-183 Reduced 11.57%
1,398 $0
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $42,871 - $48,351
-191 Reduced 10.78%
1,581 $356,000
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $63,445 - $70,603
275 Added 18.37%
1,772 $431,000
Q1 2022

May 04, 2022

SELL
$219.27 - $242.57 $8,770 - $9,702
-40 Reduced 2.6%
1,497 $362,000
Q4 2021

Feb 17, 2022

BUY
$198.88 - $227.6 $305,678 - $349,821
1,537 New
1,537 $346,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Titleist Asset Management, Ltd. Portfolio

Follow Titleist Asset Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Titleist Asset Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Titleist Asset Management, Ltd. with notifications on news.